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Background: Malaria infection in pregnancy is a major risk factor for maternal and child death, and substantially
increases the risk of miscarriage, stillbirth and low birthweight. The aim of this study therefore is to assess the
prevalence and determinants of Intermittent preventive treatment of Malaria [IPTp] utilization by pregnant women
in a rural town in Western Nigeria.
Methods: This study is an analytical cross-sectional study. All pregnant women that were due for delivery and were
attending the three primary health care center in Sagamu town, Nigeria within a 2 months period were recruited
into the study. A semi- structured questionnaire was used to collect relevant information.
Results: A total of 255 pregnant women were recruited into the study. The mean age of respondents was
28.07 ± 5.12 years. The mean parity and booking age was 2.7 ± 1.67 and 4.42 ± 1.7 months respectively. The
prevalence of Malaria attack in the last 3 months was 122(47.8%). Only 107/255 (40.4%) practice IPTp for malaria
prevention during the current pregnancy, with only 14.6% of them taking the second dose during pregnancy as
recommended. Chloroquine [27.1%] was the most frequently used medication for the treatment of Malaria in
Pregnancy. Early booking age [OR = 1.11, C.I = 0.61–2.01], adverse last pregnancy outcome [OR = 1.23, C.I = 0.36–4.22],
and parity [OR = 1.87, C.I = 0.25–16.09] were not statistically significantly associated with IPTp utilization. The only
predictor of IPTp use was the knowledge of prophylaxis for malaria prevention [OR = 2.47, C.I = 1.06–3.52] using
multivariate analysis.
Conclusion: The study concludes that most women who attend ANC in rural areas in Nigeria do not receive IPTp
as expected. A major determinant of utilization of IPTp among the study population was the knowledge of
prophylaxis for malaria prevention. This study highlights the importance of health education of the pregnant
women in increasing IPTp uptake despite the regular drug stock out at the facility level in rural areas in low
resource countries.
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The greatest impact of the malaria burden is felt in sub-
Saharan Africa where up to 90% of the global deaths due
to the disease occur [1,2] and where populations have
been severely impoverished while trying to combat the
disease for several decades [3,4]. About 250 million cases
of malaria are recorded each year, with an estimated* Correspondence: drfamoran@yahoo.com
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reproduction in any medium, provided the orassociated annual toll of 781,000 deaths [5]. The major-
ity of the burden of disease caused by malaria is borne
by the populations living in the highly endemic areas of
sub-Saharan Africa. Within these areas, the populations
at highest risk are pregnant women and infants [6].
Malaria infection in pregnancy is a major risk factor
for maternal and child health, and substantially increases
the risk of miscarriage, stillbirth and low birth weight
[3,7]. Pregnant women are especially susceptible to the
disease in areas of stable transmission. In these areas,
malaria is estimated to affect 30 million pregnanciesl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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allow for development of the fetus is one of the reasons
adduced for the increased susceptibility of pregnant
women to malaria [8]. It is estimated that 18% of severe
anaemia in pregnancy is secondary to malaria [3]. In
Sub-Saharan Africa alone an estimated 200,000 to
500,000 pregnant women develop severe anaemia [3]. In
a study in rural Kenya, the prevalence of anaemia in
pregnancy was found to be 75.6% among primigravidae
[9]. Explanations for malarial anaemia include direct de-
struction of a large number of infected erythrocytes as
the life cycle of the Plasmodium requires that it multi-
plies within the infected erythrocytes and ultimately
cause them to burst [9].
Nigeria has adopted the policy recommended by WHO
protecting the women during pregnancy using intermit-
tent preventive treatment (IPTp) with one curative regi-
men of sulphadoxine-pyrimethamine (SP) (1,500 mg
sulphadoxine and 75 mg pyrimethamine), at least twice
during pregnancy, once during the 2nd trimester, and then
at least one month apart since the year 2005. Intermittent
Preventive Treatment of Malaria in Pregnancy (IPTp)
involves giving a curative treatment dose of an effective
anti-malaria drug at predefined intervals during preg-
nancy. Anti-malaria chemoprophylaxis for pregnant
women living in endemic areas has been recommended
for many years but the practice has been limited to the
use of chloroquine and pyrimethamine [10,11]. IPTp with
SP has proven efficacious in reducing the burden of
pregnancy-associated malaria (PAM), and is currently part
of the national malaria prevention programme in most
African countries. WHO guidelines recommend a
multi-pronged approach including both preventive and
curative measures [12-14]. The Focused Antenatal Care
approach recommends: 1) Focused antenatal care and
health education: 2) Use of insecticide treated nets
(ITNs): 3) Case management of women with features
of clinical malaria: 4) Use of Intermittent Preventive
Treatment of Malaria in Pregnancy (IPTp). National
community survey 2008 Nigeria Demographic and
Health Survey reported that only 6.5% of pregnant
women had taken the recommended two doses of SP
during pregnancy [15].
A recent study in Nigeria has compared three stud-
ies performed in Benin, showing that sulphadoxine-
pyrimethamine given during pregnancy is effective
both in reducing the low birth weight rate, as com-
pared to chloroquine prophylaxis (10% with SP-IPTp
given as national policy and 8.7% in a controlled IPTp
trial [16], vs. 15.7% with chloroquine [17], and the
malaria placental infection prevalence rate (11.2% vs.
2.9% and 16.7%, respectively), with a good overall
compliance with the national IPTp policy[18]. Ap-
proximately one in four women show evidence ofplacental infection at the time of delivery, with a large
fraction of infection remaining undetected and un-
treated [19]. The health consequences of malaria in-
fection during pregnancy are large: malaria-induced
low birth weight is estimated to account for up to
360,000 infant deaths every year [20]; overall, 11.4% of
neonatal deaths and 5.7% of infant deaths in malaria-
endemic areas of Africa are estimated to be caused by
malaria in pregnancy [21,22]. But despite these obser-
vations pregnancy-related malaria remains a major
cause of adverse pregnancy outcomes and effective ac-
cess to malaria prevention in pregnancy remains lim-
ited in the country. The aim of this study therefore is
to assess the prevalence and determinants of IPTp
utilization by pregnant women in a rural town in
Western Nigeria. Although there have been many pre-
vious studies on malaria morbidity and mortality in
pregnant women and their babies, reports are scanty
on the actual practice of IPTp in particular. There is
paucity of information on whether the pregnant
women actually use the drugs in the manner recom-
mended by the WHO.Methodology
Study design
This was a analytical cross-sectional study that sought to
determine the pattern of IPTp utilization by pregnant
women in Sagamu, Nigeria. All consenting pregnant
women who attended antenatal clinic at least twice and
were due for delivery were eligible to participate in the
study.Study area
The study was carried out in Sagamu, the biggest town
in Sagamu Local Government Area (LGA) located about
midway between Lagos the commercial nerve center of
Nigeria and Ibadan, the largest city in West Africa. It
has an estimated land area of 20.05 km2. It is bounded
on the West by Obafemi |Owode Local Government
Area, on the east by Ikenne Local Government and by
Ogijo town on the South. Sagamu has a population of
135,000 inhabitants projected from the 1991 census
figure and consists mainly of Remo-speaking people of
Ogun State. An estimated 40,000 of the women are of
child bearing age. There are 15 political wards in the
Local Government. Eleven of these are within Sagamu
metropolis. Health facilities in the town include a Teach-
ing Hospital, 42 private hospitals majority of which pro-
vide ante natal care services, 12 maternity homes and 30
registered birth attendants. Although the Local Govern-
ment contains seven centres for primary health care ser-
vices, only three within the metropolis were providing
ANC activities at the time of the study. The others were
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problems.
Sampling technique
The minimum sample size required for the study
was estimated to be 246 using the formula N ¼
P 1 Pð Þ Zα=Dð Þ2
where n is the sample size,
Zα is the standard normal deviate, set at 1.96 (for 95%
confidence level),
d is the desired degree of accuracy (taken as 0.05)
p, is the estimate of the proportion of pregnant women
who practice IPTp = 6.5% [15].
A total of 47 women was calculated.
All women [a total of 255 women] who have had at
least two antenatal visits and were due for delivery at the
three designated primary health care centres over the
period of study were eligible for the study were recruited
into the study within a 2 months period.
Data collection
Women who consented to partake in the survey were
interviewed using a structured questionnaire, which was
administered by four trained interviewers between Febru-
ary and March 2008. The interviewers were all female and
had assisted in similar studies in the past. The data were
collected on antenatal clinic days by the interviewers at
the respective health care facilities. Completed question-
naires were scrutinized on the spot and at the end of daily
field sessions for immediate correction of erroneous entry.
Research instrument
The questionnaire was pretested among 20 women re-
ceiving antenatal care at similar health care facilities in
Abeokuta. Appropriate adjustments were then made to
the questionnaire to improve its internal validity. The in-
strument was a structured questionnaire which con-
tained 39 items and was divided into 6 sections, namely
socio-demographic;
Knowledge of malaria prophylaxis was determined by
assessing the correct answer given to a set of 4 simple
questions about the cause, transmission, consequences’
and the need for prophylaxis to prevent Malaria in preg-
nancy such as
What is the cause of Malaria?
Can Malaria be transmitted to unborn child during
pregnancy?
What are the consequencies of Malaria in pregnancy
[with options]?
Can sulphadoxine-pyrimethamine [fansidar] be used to
prevent Malaria in pregnancy?100% was taken as having a good knowledge of Malaria
prophylaxis in pregnancy.
IPTp use was defined as those that used SP for at least
once in pregnancy for prevention of Malaria.
Information and counseling on malaria during preg-
nancy, use of malaria prevention treatment, experience
of malaria disease during pregnancy and use of insecti-
cide treated nets were also assessed.
The socio-demographic section included information
on socio-demographic data such as age, marital status,
parity, number of living children, occupation of the
woman and her husband, educational level completed.
Others were duration of pregnancy at the time of inter-
view, duration of pregnancy at the first antenatal visit.
The other sections explored women’s knowledge and ac-
cess to information on malaria.
Criteria for inclusion
Subjects recruited into the study fulfilled the following
criteria
 Have had at least one antenatal clinic visit before
the interview. This was used as proof that they have
been registered in that facility.
 Only pregnant women that were due for delivery
were interviewed
Criteria for exclusion
 Registering for the first time in the health facility.
 Disabilities that disallowed responses to
questionnaire.
 Refusal to partake in study.
Ethical consideration
Ethical clearance was obtained from the Olabisi Ona-
banjo Teaching Hospital Ethics Board. Confidentiality
on candidate's information was maintained. Permission
of the State Ministry of Health was obtained before the
commencement of the study.
At each of the selected study site, the matron and
medical officer in-charge were informed for consent and
antenatal clinic day(s) before the commencement of the
study. The purpose, general content and nature of the
study were explained to each respondent to obtain ver-
bal and written consent before inclusion into the study.
Data analysis
The data were coded and entered into a computer
database using EPI INFO 2002 statistical software
(CDC and WHO 2002). Percentages or means and
standard deviations were computed for baseline charac-
teristics of women interviewed. Cross tabulations that
Table 1 Malaria prevention practices among respondents
No. of respondents Percent (%)
Type of dugs taken for the treatment of Malaria in Pregnancy
Chloroquine 33 27.1
Sulphadoxine-pyrimethamine (SP) 21 17.1
Arthemisinin 17 13.9
Native medication 20 16.4
Camoquine 31 25.4
Total 122 100.0





Timing of use of IPTp
1 Trimester 27 26.2
2 Trimester 72 66.0
3 Trimester 8 7.8
Total 107 100.0
Time after initial dose second dose taken
1st week 48 46.6
2nd week 15 14.6
3rd week 8 7.8
4th week 15 14.6
Not taken 21 16.5
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done. The relationship between socio-demographic char-
acteristics of the women and their use or non-use of inter-
mittent preventive treatment of malaria during pregnancy
was examined through bivariate analysis, by computing
odds ratio at 95% confidence level. A p-value < 0.05 was
considered as statistical significance.
Result
The socio-dermographic characteristics and obstetric
history of respondents
The socio-demographic characteristics of the respon-
dents interviewed at the various health facilities are pre-
sented below. The mean age was 28.07 ± 5.12 years. 232
(91.0%) of the respondents were married and only a few
(6.7%) were single. Among the participants, 20(7.8%) of
the respondents had no formal education, 45(17.6%) had
primary education, 120 (47.1%) had secondary school
education, 70 (31.1%) had post secondary school educa-
tion. 87(34.1%) of the respondents were artisans, 15
(5.9%) were students, 29(11.4%) were petty traders, 93
(38.5%) had a white collar job, while 31 (12.2%) were
unemployed.
The majority of the women were multiparous while
about a quarter of them were expecting their first babies.
The mean parity was 2.7 ± 1.67 and the median parity
was 3.0. Less than one-tenth of the respondents were
grand-multips those who have never had a child and
those who have no children alive were 106 (41.6%). Less
than one-quarter of them had at least one child alive.
Majority of the mothers (77.6%) booked between the
gestational ages of 3 and 6 months with 4 months being
the most frequently preferred month for initiating ante
natal care. The mean booking age of the women was
4.42 ± 1.7 months. 195 women (76.5%) had experienced
previous deliveries. The interval between the last child
birth and current pregnancy for over a quarter of the
women (26.2%) was 2 years.
Malaria knowledge and prevention ractices
Most of the mothers, (45.9%) believes that the risk of
malaria increases with pregnancy. More than half
(52.9%) knew that malaria is associated with low birth
weight while (45.9%) knew that malaria can cause both
pregnancy loss and maternal anaemia. One hundred and
fifty four (60.4%) of the respondents reported they
received some information on malaria prevention during
pregnancy. As depicted in Table 1 nurses and doctors
were the major source of information to well over half
(68.9%) of the respondents while chemists were the
source of information to 7.1% of the women on malaria
during pregnancy. The rest of the women who got infor-
mation on malaria during pregnancy got it through
other sources (such as the media, friends, faith basedorganization, etc.). 122(47.8%) reported that they had
Malaria attack in the last 3 months. .Chloroquine
[27.1%] was the most frequently used medication for the
treatment of Malaria, followed by Sulphadoxine-
pyrimethamine (SP) [17.1%], arthemisinin based com-
bination therapy [13.9%] and native medication [16.4%].
Of the 255 mothers who participated in the study, only
33(12.9%) of the respondents slept under ITN during
their current pregnancies.
Intermittent preventive treatment of malaria
Among all the respondents 107/255 (40.4%) reported tak-
ing medications [SP] for malaria prevention [IPTp] during
the current pregnancy. Majority of the mothers (84.4%)
who reported to have taken drugs for malaria prevention
during pregnancy took the drug at home. The remaining
13(12.6%) took the medications at the health facilities.
Most (66.0%) of the women took the drugs during the sec-
ond trimester of pregnancy, while only a quarter of them
took the first dose of malaria preventive therapy during
the first trimester. These facts are further shown in
Table 1. Of the 107 women who started anti-malarial
medication for prevention during pregnancy 86 (83.3%)
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with only 14.6% of them using it as recommended at 4th
week following the initial dose. Reasons given for not tak-
ing SP included not been informed by health workers,
afraid of safety of drug, drug stock out, did not remember
to buy etc.
The utilization of IPTp was not statistically signifi-
cantly associated with older age {>24 year} [OR= 1.14, C.
I = 0.22–5.95], Higher level of education (above second-
ary school) [OR= 0.72, C.I = 0.23–2.24] and white collar
job [OR=1.05, C.I = 0.42–2.61]. However, the knowledge
of prophylaxis for malaria prevention had a statistically
significant relationship with use of IPTp, [OR= 3.19, C.
I = 1.26–8.42]. Furthermore IPTp use was not statisti-
cally significantly associated with obstetric history such
as early booking age [OR= 1.11, C.I = 0.61–2.01], adverse
last pregnancy outcome [OR= 1.23, C.I = 0.36–4.22], and
parity [OR= 1.87, C.I = 0.25–16.09]. This is illustrated in
Tables 2 and 3.
Predictors of utilization of IPTp
Table 4 shows the adjusted odds ratio for factors asso-
ciated with utilization of IPTp among the study popula-
tion. The only predictor of IPTp use was the knowledge
of prophylaxis for malaria prevention [OR= 2.47, C.
I = 1.06–3.52] after controlling for the effect of confoun-
ders using multivariate analysis.Table 2 Socio-dermographic characteristics and IPTp use
% IPTP non users No [%] % IPT
Age
15–19 yrs 5 [3.4] 5 [4
20–24 yrs 28 [18.9] 21 [1
25–34 yrs 99 [66.9] 67 [6
>35 yrs 16 [10.8] 14 [1
Total 148 [100.0] 107 [1
Educational level
Nil 13 [8.8] 7 [6
Primary 21 [14.2] 24 [2
Secondary 74 [50.0] 46 [4
Tertiary 40 [27.0] 30 [2
Occupation
Unemployed 19 [12.8] 12 [1
Students 8 [5.4] 7 [6
Traders 18 [12.2] 11 [1
Artisans 45 [30.4] 42 [3
White collar jobs 58 [39.2] 35 [3
Knowledge of Malaria prophylaxis in Pregnancy
Adequate 121 [81.8] 100 [9
Not-adequate 27 [18.2] 7 [6Discussion
Utilization [40.4%] of SP (the drug recommended by the
policy for IPTp) for preventive treatment of malaria with
14.6% taking the second dose at the appropriate time
was very low among the study population and only
12.9% sleeping under ITN. This observation has been
made by several other studies in Nigeria and other part
of Africa [15,23,24]. Even lower prevalence was reported
in the National community survey 2008 Nigeria Demo-
graphic and Health Survey with only 11.8% of pregnant
women slept under an ITN, and only 6.5% of pregnant
women had taken the recommended two doses of SP
during pregnancy [15]. This observation has been attrib-
uted to fear of the safety of SP during pregnancy on the
part of the health workers and also unavailability of the
drugs at the facility due to stock out. This indicates that
programs that will be geared towards increasing the
knowledge and awareness of the importance of IPTp
and other preventive measures for Malaria prevention
should be introduced among this vulnerable population
in the rural areas in Africa. This will definitely lead to
reduction in maternal mortality since most of the death
comes from this rural environment.
The reported prevalence of malaria among the study
population was about 48%. This is similar to report by
several other studies [23,24]. This is not surprising since
most of the women did not benefit from proper IPTp,P use No [%] Total No [%] ODDS RATIO [C.I]
.7] 10 [3.9] 1.00
9.6] 49 [19.2] 1.33 [0.28–6.29]
2.6] 166 [65.1] 1.48 [0.35–6.18]
3.1] 30 [11.8] 1.14 [0.22–5.95]
00.0] 255 [100.0]
.5] 20 [8.9] 1.00
2.4] 45 [20.0] 0.47 [0.14–1.58]
3.0] 120 [53.3] 0.87 [0.29–2.55]
8.0] 70 [31.1] 0.72 [0.23–2.24]
1.2] 31 [12.2] 1.00
.5] 15 [5.9] 0.72 [0.17–2.98]
0.3] 29 [11.4] 1.03 [0.32–3.33]
9.3] 87 [34.1] 0.68 [0.27–1.69]
2.7] 93 [36.5] 1.05 [0.42–2.61]
3.5] 221 [86.7] 3.19 [1.26–8.42]
.5] 34 [13.3] 1.00
Table 3 Obstetric history and IPTp use
% IPTP non users No [%] % IPTP use No [%] Total No [%] ODDS RATIO [C.I]
Booking age
Ist trimester 42 [28.4] 33 [30.8] 75 [29.4] 1.00
2nd trimester 92 [62.2] 65 [60.8] 157 [61.6] 1.11 [0.61–2.01]
3rd trimester 14 [9.4] 9 [8.4] 23 [9.0] 1.22 [0.43–3.53]
Last Pregnancy Outcome
Nil Birth 19 [12.8] 21 [19.6] 40 [15.7] 1.00
Still Birth 10 [6.8] 9 [8.4] 19 [7.5] 1.23 [0.36–4.22]
Preterm 0 [0.0] 2 [1.9] 2 [0.8] 0.00 [0.00–5.12]
Live Birth 119 [80.4] 75 [70.1] 194 [76.1] 1.75 [0.84–3.67]
Parity
0 31 [20.9] 29 [2.7] 60 [23.5] 1.00
1–2 73 [49.3] 56 [52.3] 129 [50.6] 1.22 [0.63–2.36]
3–4 40 [27.0] 20 [18.7] 60 [23.5] 1.87 [0.84–4.19]
>5 4 [2.7] 2 [1.9] 6 [2.4] 1.87 [0.26–16.09]
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remains high. Of note is the finding that chloroquine
was still the most frequently used drug for treating mal-
aria during pregnancy by these women. More worrisome
is the high proportion still taking native medication.
This calls for the proper implementation of the National
policy on Malaria treatment and prevention which has
been shown to significantly reduce malaria related mor-
bidity and deaths in pregnant women [12,13].
The average gestational age of booking for ANC by
participants in this study was 4 months. While a few ofTable 4 Predictors of utilization of IPTp
Characteristics Adjusted Odds ratio [C.I]
Booking age
Ist trimester 1.00
2nd trimester 1.51 [0.82–2.75]
3rd trimester 1.41 [0.74–5.88]
Last Pregnancy Outcome
Nil Birth 1.00
Still Birth 1.09 [0.72–3.54]
Preterm 0.00 [undefined]






Knowledge of Malaria prophylaxis in Pregnancy
Adequate 2.47 [1.06–3.52]
Not-adequate 1.00them booked early the number of mothers booking
increased gradually, and got to a peak during the second
trimester and then gradually declined as pregnancy
neared term. This pattern of ANC booking is a deviation
from the regular one in this environment which is char-
acterized by late booking by majority of mothers [24,25],
and clearly reflects an interaction of several factors, chief
among which is the high level of education of the
women. Their maturity in terms of age, and the fact that
many of them have had contact with ANC services be-
fore (most were multips) were also important contribu-
tors to this pattern. It is of concern therefore that
despite their presenting at a good time for information
on, and application of IPTp most of these mothers
reported that they neither received information on this
policy nor took the treatment. This calls for a review of
the implementation of this policy which has been shown
to significantly reduce malaria related morbidity and
deaths in pregnant women. In a related work in Nigeria
and Tanzania [26,27] it was found that more than half of
pregnant mothers first attendees at ANC do not receive
IPTp on their first visit. This study suggests that the
PHC health workers should be trained on the import-
ance of IPTp in the prevention of Malaria and its com-
plication and the need to strictly implement this policy
at the PHC.
A major determinant of utilization of IPTp among the
study population was the knowledge of prophylaxis for
malaria prevention. For pregnant women to use IPTp
properly they must be well informed about the dangers
of pregnancy-related malaria and receive the appropriate
therapy at the right time during pregnancy. The focus
on community directed interventions in the design of
Preventive intervention is essential. This highlights the
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in the delivery of health services in general, and prevent-
ive health measures in particular. Several studies have
reported similar experiences [28-35]. While the involve-
ment of community workers does not necessarily medi-
ate socioeconomic differences within communities [36],
the overall health improvements achievable through
community based interventions appear large [29,37].
Health education of the community will increase IPTp
uptake despite the regular drug stock out at the facility
level.
Our study has certain limitations. The study findings
are limited in terms of overall generalization and impact
since the study might also have been faced with recall
bias. Furthermore the study was conducted at the health
facilities, and this may lead to selection bias as the situ-
ation of pregnant women who do not attend the health
facility is not known. Despite these limitations, we be-
lieve that our data provide useful information for the as-
sessment and implementation of IPTp in Nigeria and
will also inform policy decision in Nigeria and other low
income countries.
Conclusion
The study concludes that most women who attend ANC
in rural areas in Nigeria do not receive IPTp as
expected. A major determinant of utilization of IPTp
among the study population was the knowledge of
prophylaxis for malaria prevention. Uptake of IPTp can
be significantly improved in rural areas if backed up with
appropriate health education intervention. This study
highlights the importance of community health educa-
tion in the delivery of health services in general, and
preventive health measures in particular.
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